5-amino-2-(aminomethyl)-6-({4,6-diamino-2-[(4-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxycyclohexyl}oxy)oxane-3,4-diol; sulfuric acid

• ChemBase编号: 105804
• 分子式: C23H48N6O17S
• 平均质量: 712.72222
• 单一同位素质量: 712.27966511
• SMILES: NCC1OC(OC2C(N)CC(N)C(O)C2OC2OC(CO)C(OC3OC(CN)C(O)C(O)C3N)C2O)C(N)C(O)C1O.OS(=O)(=O)O
• Canonical SMILES: OS(=O)(=O)O.OCC1OC(C(C1OC1OC(CN)C(C(C1N)O)O)O)OC1C(O)C(N)CC(C1OC1OC(CN)C(C(C1N)O)O)N
• InChI: InChI=1S/C23H46N6O13.H2O4S/c24-2-7-13(32)15(34)10(28)21(37-7)40-18-6(27)1-5(26)12(31)20(18)42-23-17(36)19(9(4-30)39-23)41-22-11(29)16(35)14(33)8(3-25)38-22;1-5(2,3)4/h5-23,30-36H,1-4,24-29H2;(H2,1,2,3,4)
• InChIKey: OIXVKQDWLFHVGR-UHFFFAOYSA-N

名称和登记号

名称

• IUPAC标准名: 5-amino-2-(aminomethyl)-6-({4,6-diamino-2-[(4-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxycyclohexyl}oxy)oxane-3,4-diol; sulfuric acid
• IUPAC传统名: 5-amino-2-(aminomethyl)-6-({4,6-diamino-2-[(4-{[3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl)oxy]-3-hydroxycyclohexyl}oxy)oxane-3,4-diol; sulfuric acid
• 别名: Neobiotic; Otobiotic; Biosol Veterinary; Bykomycin; Fradiomycin sulfate; Mycaifradin sulfate; NEOMYCIN SULFATE

登记号

• CAS号: 1405-10-3
• EC号: 215-773-1
• PubChem SID: 162092836
• PubChem CID: 291576

理论计算性质

• Acid pKa: 12.291083
• 质子受体: 19
• 质子供体: 13
• LogD (pH = 5.5): -24.511583
• LogD (pH = 7.4): -15.933928
• Log P: -8.415177
• 摩尔折射率: 135.9003 cm^3
• 极化性: 58.22208 Å^3
• 极化表面积: 353.11 Å^2
• 可自由旋转的化学键: 9
• 里宾斯基五规则: false

分子性质

安全信息

• 保存条件: Room Temperature (15-30°C), Desiccate, Protect from light
• RTECS编号: QP4375000
• 欧盟危险性物质标志: 刺激性(Irritant) (Xi)
• 危险公开号: R:36
• 安全公开号: S:26

详细说明

MP Biomedicals - 02194533

Cell Culture Reagent
Minimum 630 μg Neomycin/mg
White powder.
Approx. 90-95% Neomycin B.
Antibiotic
Acts as an inhibitor of protein biosynthesis.